from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3887c/eccD2

LFCtreatmentdescriptionclass of inhibitor

-1.273

Amikacinug/mL Amikacintranslation

-0.747

Cap5-10ug/mL Capreomycintranslation

-2.459

Rox10-50 ug/mL Roxithromycintranslation

0.272

SM2-5 ug/mL Streptomycintranslation

-3.735

Tet5-10 ug/mL Tetracyclinetranslation

-0.195

Rif0.2-5ug/mL Rifampicintranscription

0.297

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.442

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.494

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.005

CPZ10-50 ug/mL Chlorpromazinerespiration

1.044

Clofazimine10-13 ug/mL Clofaziminerespiration

0.664

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.215

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.730

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.075

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.893

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.046

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.013

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.037

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.118

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.848

KCN5-20 ug/mL Potassium cyaniderespiration

0.588

NaN30.2-2 mM Sodium aziderespiration

0.818

Nigericin50 uM Nigericinrespiration

-0.697

TRC10-150 ug/mL Triclosanrespiration

-1.054

TRZ10-25 ug/mL Thioridazinerespiration

-1.204

Valinomycin0.5-10 uM Valinomycinrespiration

-0.471

ZnSO42 mM ZnSO4respiration

-0.201

menadione6-10 ug/mL Menadionerespiration

0.643

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.559

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.778

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.693

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.595

NRP_1Non-replicating persistence stage 1dosRassociated

0.842

Amp0.2mg/mL AmpicillincellWall

-0.056

Cephalexin20-100 ug/mL CephalexincellWall

0.561

Cerulenin0.32-5 ug/mL CerulenincellWall

0.401

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.264

EMB10-20 ug/mL EthambutolcellWall

0.146

Eta12-40 ug/mL EthionamidecellWall

0.337

INH0.2-0.4 ug/mL IsoniazidcellWall

0.204

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.220

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.986

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.239

BZA0.12 mg/mL BenzamidearomaticAmides

-0.097

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.326

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.146

H2O24 mM hydrogen peroxideDNAdamaging

-0.005

Levo10 ug/mL LevofloxacinDNAdamaging

-0.145

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.367

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.200

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.211

UVUV-irradiationDNAdamaging

-0.497

ARP41-4 ug/mL Antitubercular compound ARP4?

0.466

Antimycin12.5-50 ug/mL Antimycin A?

0.285

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.011

PA_110-50 ug/mL Antitubercular compound PA-1?

0.733

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.159

PA8240.2-2 ug/mL PA-824?

-0.610

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.134

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.073

Verapamil50 uM Verapamil?

0.773

mercaptoethanol2 mM 2-Mercaptoethanol?

0.671

methoxatin10-20 ug/mL Methoxatin?